ch 1

Human IgG1 CH1-Human IgG2 Fc-Kappa Isotype control is the isotype control for Human IgG1 CH1+Human IgG2 Fc-Kappa antibody.

Brontictuzumab (OMP 52M5) is a monoclonal antibody that targets Notch1 and inhibits activation of the pathway. It has antitumor activity, inhibits tumor cell proliferation, and can be used in the study of leukemias and lymphomas.

Anti-NOTCH1 Antibody is a human-derived antibody expressed in CHO cells, targeting NOTCH1. It features a huIgG2 heavy chain and a huλ light chain, with a predicted molecular weight (MW) of 150 kDa. For its isotype control, refer to HumanIgG2kappa, Isotype Control.